CGP is an advanced, NGS-based test that analyzes tumor DNA to find specific changes (mutations) that may be driving its growth. These changes can help oncologists:
Identify effective targeted therapies or immunotherapies
Check eligibility for clinical trials
Avoid treatments that may not work for a specific cancer
Unlike older, conventional tests that check just 1 or 2 genes, CGP looks at hundreds of cancer-related genes all at once to give a complete genetic picture of a tumor.
CGP Can Help Answer:
Is there a drug that works specifically for my cancer type and mutation?
Do I qualify for a clinical trial?
Is immunotherapy an option?
Can I avoid chemotherapy or certain toxic treatments?
Comprehensive Report for Maximum Insight
Each CGP test report includes:
Detected mutations with clear clinical interpretation
Biomarker summary (MSI, TMB as applicable)
List of FDA-approved therapies linked to your tumor profile
Clinical trial options based on your cancer type and genetic alterations